The Bhubaneswar-based company grows drug crystals in microgravity, where the absence of gravity may produce purer forms than are possible on Earth.
A drug is only as good as its crystals.
The way a molecule arranges itself as it solidifies determines how well it dissolves, how stable it is on a shelf, and how much of it the body can absorb.
Get the structure wrong, and a medicine that works in theory fails in practice.
Gravity interferes with that process.
As a crystal forms in solution, denser material sinks and convection currents stir the liquid, both of which introduce defects.
BioOrbit hopes drug-crystallisation technology will lead to self-injected cancer treatment that could save millions
Space, which have been largely dominated by rockets, satellites and astronauts up until now, is gearing up to welcome a…
Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.
Varda’s plan to develop medicines in microgravity has its advantages, but it requires a big up-front cost
United Therapeutics is collaborating with Varda Space Industries to test pharmaceuticals in outer space.
The space startup is collaborating with United Therapeutics Corporation to manufacture commercial drugs in orbit.
